跳至主要内容
临床试验/NCT00624689
NCT00624689已完成不适用

Double-blinded Interventional Study on the Effects of MFGM-enriched Formula With Reduced Energy and Protein Content on Growth and Development

Umeå University1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
240
试验地点
1
主要终点
Body composition

研究概览

简要总结

Formula-fed infants differ from breast-fed infants in the growth pattern, risk for obesity and cardiovascular diseases, neurological development and morbidity in infections.

The investigators' hypothesis is that a modified formula with reduced energy and protein content and enrichment with Milk Fat Globule Membrane (MFGM) containing bioactive proteins and phospholipids will reduce the difference between formula-fed and breast-fed infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 2 Months(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Term infants with birth weight 2500-4500 gr
  • •Fed with breastmilk only or formula only before 2 months of age

排除标准

  • •Chronic illness

研究组 & 干预措施

1

Experimental

Modified formula

干预措施: Modified formula (MFGM-enriched formula with reduced energy and protein content) (Dietary Supplement)

2

No Intervention

Standard formula

3

No Intervention

Breastfed

结局指标

主要结局

Body composition

时间窗: 4 months

Pletysmography (% body fat)

次要结局

  • Neurological development(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Niklas Timby

M.D, Researcher

Umeå University

研究点 (1)

Loading locations...

相似试验